Open Access

[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2

  • Authors:
    • Lei Xu
    • Bin Zhang
    • Wenlan Li
  • View Affiliations

  • Published online on: July 30, 2024     https://doi.org/10.3892/mmr.2024.13297
  • Article Number: 173
  • Copyright : © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

October-2024
Volume 30 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu L, Zhang B and Li W: [Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2. Mol Med Rep 30: 173, 2024.
APA
Xu, L., Zhang, B., & Li, W. (2024). [Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2. Molecular Medicine Reports, 30, 173. https://doi.org/10.3892/mmr.2024.13297
MLA
Xu, L., Zhang, B., Li, W."[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2". Molecular Medicine Reports 30.4 (2024): 173.
Chicago
Xu, L., Zhang, B., Li, W."[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2". Molecular Medicine Reports 30, no. 4 (2024): 173. https://doi.org/10.3892/mmr.2024.13297